Contraceptives Market expected to reach USD 47.386 billion by 2030
Contraceptives Market Size & Growth
According to a research study published by Knowledge Sourcing Intelligence (KSI), the contraceptive market will expand from USD 34.613 billion in 2025 to USD 47.386 billion in 2030 at a CAGR of 6.48% during the forecast period.
The use of drugs or devices to prevent pregnancy in women is known as contraception. Other names include birth control and fertility control. As the prevalence of STDs increases, the market is anticipated to keep expanding. More women are looking for contraceptive medications and devices, especially young women starting to utilize contraception as their educational attainment increases.
Women in both rural and urban regions are now more aware of family planning and contraception as a result of government initiatives to slow population growth in some nations. Additionally, the use of oral contraceptives has grown due to an increase in unplanned births, particularly in industrialized economies. The microeconomic balance is being impacted by the astonishing pace of population growth, especially in Asian nations. In the years to come, sex education and the usage of contraception could benefit from the collaboration between the public and commercial sectors to control this expanding population. Throughout the forecast period, this is anticipated to propel the oral contraceptive market’s revenue.
As women’s knowledge grows and their lifestyles change, wearable equipment for tracking the movements of unborn children is becoming more popular. From conception to delivery, pregnancy gadgets are helpful for the whole pregnancy. Certain baby health monitors and home ultrasounds give parents vital information about their unborn kid. Wearable technology is starting to be employed in hospitals and home health care in tiny, portable, and cost-effective ways. It facilitates fetal development monitoring.
The problem with contraceptives is exacerbated by cultural taboos around discussions of reproductive health, which frequently prevent candid dialogue and the spread of pertinent information. Further discouraging the use of contraceptives are false, inflated worries about long-term health hazards or adverse effects. Because of this circumstance, many people are unable to make informed judgments, which eventually lowers adoption rates and raises the number of unintended pregnancies.
Businesses in the sector are spending money on R&D to produce cutting-edge goods that cater to a wide range of customer demands. To increase the usage of current birth control techniques, for example, Bayer and the U.S. biotech company Daré Bioscience collaborated in February 2024 to develop a hormone-free monthly contraception. For three weeks, the contraceptive device—a ring that is inserted into the vagina—works without the user needing to do anything while engaging in sexual activity.
The contraceptives market includes a wide range of product types including drugs and condoms. By distribution channel, the market is segmented into online and offline. The market is further segmented based on age group which include 15–24 years, 25–34 years, 35–44 years, and above 44 years.
➥ View a sample of the report or purchase the complete study at: Contraceptives Market Report
Contraceptives Market Report Highlights
- Despite being a smaller market share contributor than contraceptive devices, the contraceptive drugs category is anticipated to rise at a promising rate throughout the projection period. It is due to a number of factors, including the widespread use of medications by women to avoid getting pregnant, the pharmaceuticals category is expected to develop at a quicker rate throughout the forecast period.
- Because it provides ease and privacy, as well as because e-commerce is becoming more and more popular, the online category is expected to develop at a higher rate throughout the projected period. Opill®, which will be sold online and on shop shelves across the country, was distributed to pharmacies and major retailers in March 2024 by Perrigo Company plc, a well-known producer of consumer self-care goods.
- Young people’s propensity for sexual activity and their high level of understanding about reproductive health and contraception are factors contributing to the market expansion in North America. The emergence and proliferation of low-cost generic devices and consumables has increased the demand for contraception among teenagers in the areas. the growth of social organization initiatives to improve access to contraception in the US and the extension of publically supported family planning services.
Report Coverage:
Report Metric | Details |
Contraceptives Market Size in 2025 | US$34.613 billion |
Contraceptives Market Size in 2030 | US$47.386 billion |
Growth Rate | CAGR of 6.48% |
Drivers |
|
Restraints |
|
Segmentation |
|
List of Major Companies in the Contraceptives Market |
|
Contraceptives Market Drivers and Restraints
Drivers
- Increasing Awareness of Reproductive Health and Family Planning: Increasing awareness across the world about family planning, population management, and women’s health is propelling the demand for contraceptives. Government schemes, NGO activities, and advocacy programs are also fuelling adoption.
- Technological Advancements: The industry is growing due to the introduction of new products like long-acting reversible contraceptives (LARCs), hormonal IUDs, implants, and non-hormonal options. Easy-to-use formats like contraceptive patches, vaginal rings, and enhanced oral pills are paving the way to greater consumer acceptance.
Restraints
- Cultural and Religious Opposition: Cultural values, religious beliefs, and stigmatization of the use of contraceptives in most regions restrict uptake. Social resistance continues to pose the largest obstacle to market expansion.
- Side Effects and Health Issues: Hormonal contraceptives tend to come with side effects like weight gain, mood swings, and heightened risk of some health issues. These issues deter regular use and adoption among some consumers.
Contraceptives Market Key Developments
- In August 2025, Foundation Consumer Healthcare (FCH), the manufacturer of Plan B One-Step, announced the release of a full suite of official product images for the FDA-approved, number one OB/GYN-recommended emergency contraception brand.
- In July 2025, Daré Bioscience, Inc., a biopharmaceutical company driven by a mission to challenge the status quo, making women’s health a priority, announced positive interim safety and efficacy results from its ongoing Phase 3 clinical trial evaluating the contraceptive effectiveness, safety and acceptability of Ovaprene, the company’s investigational monthly, hormone-free intravaginal contraceptive.
Contraceptives Market Segmentation
Knowledge Sourcing Intelligence has segmented the contraceptives market based on product, distribution channel, age group, and region:
Contraceptives Market, By Product
- Drugs
- Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Devices
- Condoms
- Intrauterine Devices (IUDs)
- Diaphragms
- Rings
- Others
Contraceptives Market, By Distribution Channel
- Online
- Offline
Contraceptives Market, By Age Group
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
Contraceptives Market, By Region
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Others
Contraceptives Market Key Players
- Allergan plc (AbbVie)
- ANSELL LTD.
- Bayer AG
- CooperSurgical Inc.
- Merck & Co., Inc.,
- Church & Dwight Co., Inc.
- Veru Inc.
- Mayer Laboratories, Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Reckitt Benckiser Group plc
- Mankind Pharma
- Karex Berhad
- Montage Laboratory
- Pregna International Ltd.
About Knowledge Sourcing Intelligence (KSI)
Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm headquartered in India. Backed by seasoned industry experts, we offer syndicated reports, customized research, and strategic consulting services. Our proprietary data analytics framework, combined with rigorous primary and secondary research, enables us to deliver high-quality insights that support informed decision-making. Our solutions empower businesses to gain a competitive edge in their markets. With deep expertise across ten key sectors, including ICT, Chemicals, Semiconductors, and Healthcare, we effectively address the diverse needs of our global clientele.